SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-15-002742
Filing Date
2015-04-27
Accepted
2015-04-27 07:33:21
Documents
3
Period of Report
2015-04-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ctix_8k.htm 8-K 16798
2 FORM OF DIRECTOR AGREEMENT ctix_ex101.htm EX-10.1 20375
3 PRESS RELEASE ctix_ex991.htm EX-99.1 12087
  Complete submission text file 0001477932-15-002742.txt   50583
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 (978)-633-3623
Cellceutix CORP (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37357 | Film No.: 15793585
SIC: 2834 Pharmaceutical Preparations